These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8895751)

  • 1. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility.
    Cascorbi I; Brockmöller J; Roots I
    Cancer Res; 1996 Nov; 56(21):4965-9. PubMed ID: 8895751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
    Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
    Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
    Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
    Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
    Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
    Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
    Xue K; Xu L; Chen S; Ma G; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer].
    Hu Y; Zhang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):26-8. PubMed ID: 9949237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
    Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
    J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer].
    Wang BG; Chen SD; Zhou WP; Zeng M; Li ZB; Cai XL; Wang DQ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):93-7. PubMed ID: 15059326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.
    Cascorbi I; Henning S; Brockmöller J; Gephart J; Meisel C; Müller JM; Loddenkemper R; Roots I
    Cancer Res; 2000 Feb; 60(3):644-9. PubMed ID: 10676648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of CYP1A1 mutations in a Turkish population.
    Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Roots I
    Arch Toxicol; 1998 Mar; 72(4):215-8. PubMed ID: 9587016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.